# OnCo record nct06831136 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06831136/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06831136", "NCT06831136" ;
  schema:name "Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma"@en ;
  schema:alternateName "PANCARDINAL-2"@en ;
  schema:description "A phase 2 trial in pancreatic cancer, run by The University of Texas Health Science Center, Houston, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06831136/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06831136> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "pancreatic-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/locally-advanced-pdac/>, <https://onco.cc/cancers/metastatic-pdac/> .